Literature DB >> 2312606

The status of trypsin-like enzymes in squamous-cell carcinoma of the head and neck region.

F S Steven1, L A Williams, H Maier, J Arndt, H Weidauer, A Born.   

Abstract

The activity of two proteases associated with tumour cells was studied using frozen sections of squamous-cell carcinoma and fluorescent probes for the enzymes. Four fluorescent probes were used to define the enzymic status of guanidinobenzoatase on the surface of the squamous carcinoma cells. Each of four probes demonstrated the location of cells possessing inactive guanidinobenzoatase, whereas adjacent cells of the same tumour exhibited active enzyme. It was shown that the inactive form of the enzyme was an inhibitor-enzyme complex that could be dissociated. In contrast, all of the squamous carcinoma cells possessed active trypsin-like enzymes that were recognised by fluorescent aprotinin molecules. The observed variation in enzymic status of these two tumour-associated enzyme systems is discussed in the context of a possible biological control mechanism for cell migration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312606     DOI: 10.1007/bf01612641

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Inhibition of guanidinobenzoatase by a substrate for trypsin-like enzymes.

Authors:  F S Steven; M M Griffin; W F Mangel; H Maier; M Altmannsberger
Journal:  J Enzyme Inhib       Date:  1988

2.  Fibrinolysis associated with oncogenic transformation. Morphological correlates.

Authors:  L Ossowski; J P Quigley; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

3.  Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines.

Authors:  J F Cajot; E K Kruithof; W D Schleuning; B Sordat; F Bachmann
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

4.  Inhibition of trypsin-like enzymes on cells with rhodamine-aprotinin.

Authors:  F S Steven; M M Griffin; L A Williams; A J Freemont; H Maier; H Weidauer
Journal:  J Enzyme Inhib       Date:  1989

5.  Tissue-type plasminogen activator and urokinase: differences in the reaction pattern with the active-site titrant 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.

Authors:  M Geiger; B R Binder
Journal:  Biochim Biophys Acta       Date:  1987-03-18

6.  Inhibition of guanidinobenzoatase: evidence for multiple forms of this protease on different tumour cells.

Authors:  F S Steven; M M Griffin; A J Freemont; J Johnson
Journal:  J Enzyme Inhib       Date:  1988

7.  Evidence for inhibitors of the cell surface protease guanidinobenzoatase.

Authors:  F S Steven; M M Griffin; T L Wong; S Itzhaki
Journal:  J Enzyme Inhib       Date:  1986

8.  A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.

Authors:  F Steven; M M Griffin; L A Williams; G Feichter
Journal:  Anticancer Res       Date:  1988 Nov-Dec       Impact factor: 2.480

9.  Rhodamine-based compounds as fluorogenic substrates for serine proteinases.

Authors:  S P Leytus; L L Melhado; W F Mangel
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

10.  The inhibition of a tumour cell surface protease in vivo and its re-activation by oxidation.

Authors:  F S Steven; H Ali; M M Griffin
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

View more
  1 in total

1.  The role of serine proteases and serine protease inhibitors in the migration of gonadotropin-releasing hormone neurons.

Authors:  Paola T Drapkin; Denis Monard; Ann-Judith Silverman
Journal:  BMC Dev Biol       Date:  2002-02-05       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.